Yokosuka, Japan

Sayuri Itoh

This inventor holds 1 USPTO granted patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 1980.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 1980

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Journey of Sayuri Itoh

Introduction

Sayuri Itoh is a remarkable inventor based in Yokosuka, Japan, recognized for her pioneering contributions to the field of pharmaceuticals. As a dedicated researcher, she has made significant strides, particularly in the area of chiral resolution, which is crucial for the development of effective drug therapies.

Latest Patents

Sayuri holds a patent for the "Resolution of a racemate," specifically a process for the resolution of DL-N-benzyloxycarbonyl-2-(p-hydroxyphenyl)-glycine. This invention showcases her commitment to advancing the pharmaceuticals industry by providing a method to isolate specific enantiomers, enhancing the efficacy and safety of drugs.

Career Highlights

Currently, Sayuri is employed by Hoffmann-La Roche Inc., a leading company in the healthcare sector, where she continues to improve drug development processes. Her expertise in asymmetric synthesis and racemic resolutions has garnered her recognition among her peers and is pivotal to the company's ongoing innovations.

Collaborations

Throughout her career, Sayuri has collaborated with talented coworkers such as Yasuji Suhara and Hiromi Maruyama. These partnerships have fostered a creative and innovative environment, allowing her to exchange ideas and develop new solutions that push the boundaries of pharmaceutical science.

Conclusion

Sayuri Itoh exemplifies the spirit of innovation necessary for advancing modern medicine. Her contributions, highlighted by her patent and collaborations, not only enhance drug efficacy but also illustrate the importance of women in science. With a strong career foundation, Sayuri continues to aspire to new heights in her field, driving the future of pharmaceutical research and development.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…